Intellect Neurosciences Inc. (fka ILNS)

[Stately]

Here's the thing, though. Shire doesn't gain anything from terminating the agreement, do they? They weren't going to have to pay anything unless certain success criteria were met in trial. The only possible benefit I can think of is for ILNS, who can now shop OX1 around elsewhere. I'm not saying this is necessarily the case, but it's the only reason I can think of to terminate the agreement instead of simply not touch it.